Dr. Peter P. Stanich
Claim this profileOhio State University Comprehensive Cancer Center
Area of expertise
Colorectal Cancer
Peter P. Stanich has run 2 trials for Colorectal Cancer. Some of their research focus areas include:
Polyposis
Peter P. Stanich has run 1 trial for Polyposis. Some of their research focus areas include:
Affiliated Hospitals
Ohio State University Comprehensive Cancer Center
The Ohio State University Wexner Medical Center
Clinical Trials Peter P. Stanich is currently running
5-Year vs. 10-Year Colonoscopy
for Colorectal Cancer Prevention
This trial aims to determine the best schedule for preventing small, non-dangerous growths in the colon from turning into cancer by regularly checking and removing them.
Recruiting
1 award
N/A
ONC201
for Colorectal Cancer Prevention
The purpose of this phase I trial is to test the safety and cancer preventive effects of different doses of ONC201 in people with familial adenomatous polyposis (FAP) or a history of multiple polyps. People with familial adenomatous polyposis (FAP) or a history of multiple polyps are at higher than average risk of developing colorectal cancer. ONC201, now known as dordaviprone, is a drug that may stop cancer cells from growing. This drug has been shown in previous studies to cause cancer cell death but not harm normal cells. If successful, this study may help us develop a new option for colorectal cancer prevention.
Recruiting
1 award
Phase 1
More about Peter P. Stanich
Clinical Trial Related
6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Peter P. Stanich has experience with
- Sirolimus
- ONC201
- Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5
- Nogapendekin Alfa
- Placebo Administration
- 5-year And 10 Year Surveillance Colonoscopy After Qualifying Colonoscopy
Breakdown of trials Peter P. Stanich has run
Cowden syndrome
Bannayan-Riley-Ruvalcaba Syndrome
PTEN Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter P. Stanich specialize in?
Peter P. Stanich focuses on Colorectal Cancer and Polyposis. In particular, much of their work with Colorectal Cancer has involved APC positive patients, or patients who are MSH2 positive.
Is Peter P. Stanich currently recruiting for clinical trials?
Yes, Peter P. Stanich is currently recruiting for 2 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Peter P. Stanich has studied deeply?
Yes, Peter P. Stanich has studied treatments such as Sirolimus, ONC201, Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5.
What is the best way to schedule an appointment with Peter P. Stanich?
Apply for one of the trials that Peter P. Stanich is conducting.
What is the office address of Peter P. Stanich?
The office of Peter P. Stanich is located at: Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States. This is the address for their practice at the Ohio State University Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.